Theravance Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 05/15/2026 | 9.51 M | $154.37 M | 0.00% | 18.90% |
| WEISS ASSET MANAGEMENT LP | 05/15/2026 | 7.46 M | $121.03 M | 0.00% | 14.82% |
| NEWTYN MANAGEMENT, LLC | 05/15/2026 | 4.84 M | $78.58 M | 12.60% | 9.62% |
| BLACKROCK, INC. | 05/13/2026 | 4.30 M | $69.73 M | 6.07% | 8.54% |
| IRENIC CAPITAL MANAGEMENT LP | 05/18/2026 | 2.76 M | $44.81 M | 0.00% | 5.49% |
| 05/15/2026 | 1.78 M | $28.95 M | 100.00% | 3.55% | |
| STATE STREET CORP | 05/15/2026 | 1.30 M | $21.06 M | 17.74% | 2.58% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 1.28 M | $20.71 M | 9.49% | 2.54% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.26 M | $20.43 M | 134.21% | 2.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.14 M | $18.46 M | 21.17% | 2.26% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 983.62 K | $15.96 M | 14.51% | 1.95% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 954.04 K | $15.48 M | -24.28% | 1.90% |
| UBS GROUP AG | 05/05/2026 | 764.11 K | $12.40 M | 33.95% | 1.52% |
| OASIS MANAGEMENT CO LTD. | 05/15/2026 | 583.49 K | $9.47 M | -19.76% | 1.16% |
| MORGAN STANLEY | 05/15/2026 | 510.27 K | $8.28 M | -36.46% | 1.01% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 416.14 K | $6.75 M | 43.07% | 0.83% |
| INVESCO LTD. | 05/12/2026 | 409.44 K | $6.65 M | 130.09% | 0.81% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 404.15 K | $6.56 M | 0.00% | 0.80% |
| 05/08/2026 | 400.76 K | $6.50 M | 100.00% | 0.80% | |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 378.98 K | $6.15 M | -5.37% | 0.75% |
| NORTHERN TRUST CORP | 05/14/2026 | 370.53 K | $6.01 M | 12.31% | 0.74% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 341.58 K | $5.54 M | 1,460.01% | 0.68% |
| HRT FINANCIAL LP | 05/14/2026 | 328.68 K | $5.33 M | 41.15% | 0.65% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 327.55 K | $5.32 M | -66.00% | 0.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 314.00 K | $5.10 M | 100.00% | 0.62% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 310.59 K | $5.04 M | -0.86% | 0.62% |
| PACER ADVISORS, INC. | 06/18/2026 | 293.19 K | $4.76 M | -13.50% | 0.58% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 289.47 K | $4.70 M | -38.87% | 0.58% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 262.07 K | $4.25 M | 100.00% | 0.52% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 250.00 K | $4.06 M | 100.00% | 0.50% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 249.76 K | $4.05 M | 12.67% | 0.50% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 248.70 K | $4.04 M | 100.00% | 0.49% |
| MACKENZIE FINANCIAL CORP | 05/13/2026 | 248.68 K | $4.04 M | 566.19% | 0.49% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 215.64 K | $3.50 M | -33.51% | 0.43% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 208.78 K | $3.39 M | 0.00% | 0.41% |
| TREXQUANT INVESTMENT LP | 05/15/2026 | 205.78 K | $3.34 M | 12.76% | 0.41% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 05/08/2026 | 199.59 K | $3.24 M | 14.35% | 0.40% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 189.16 K | $3.07 M | 78.15% | 0.38% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 163.70 K | $2.66 M | 100.00% | 0.33% |
| MARSHALL WACE, LLP | 05/15/2026 | 158.90 K | $2.58 M | -62.04% | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 127.92 K | $2.08 M | 100.00% | 0.25% |
| NUVEEN, LLC | 04/30/2026 | 127.68 K | $2.07 M | 43.48% | 0.25% |
| JPMORGAN CHASE & CO | 05/13/2026 | 127.27 K | $1.94 M | -69.44% | 0.25% |
| FMR LLC | 05/15/2026 | 122.97 K | $2.00 M | 2,167.91% | 0.24% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2026 | 120.12 K | $1.95 M | -36.82% | 0.24% |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 05/05/2026 | 118.56 K | $1.92 M | 100.00% | 0.24% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 117.74 K | $1.91 M | 12.89% | 0.23% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 114.07 K | $1.85 M | -3.78% | 0.23% |
| ENGINEERS GATE MANAGER LP | 05/15/2026 | 113.22 K | $1.84 M | 176.09% | 0.23% |
| VERITION FUND MANAGEMENT LLC | 05/15/2026 | 110.00 K | $1.79 M | 100.00% | 0.22% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Theravance Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 255 institutional investors and hedge funds held shares of Theravance Biopharma Inc. The most heavily invested institutionals were:
Madison Avenue Partners, LP: 9.51 M
Weiss Asset Management LP: 7.46 M
Newtyn Management, LLC: 4.84 M
BlackRock, Inc.: 4.3 M
Irenic Capital Management LP: 2.76 M
STATE STREET CORP: 1.3 M
99.56% of Theravance Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 78.62 M shares in the last 24 months. This purchase volume represents approximately $1.10 B in transactions.